Literature DB >> 24011710

Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Hui Chen1,2, Annie Y Chan1,2, Donald U Stone1,2, Nawajes A Mandal1,2.   

Abstract

Sphingolipids are a ubiquitous membrane lipid present in every cell and found most abundantly in neural tissues. Disorders such as Tay-Sachs or Niemann-Pick disease are the most familiar examples of dysfunction in sphingolipid metabolism and are typically associated with neurodegeneration and ocular findings such as blindness. More recently, the role of bioactive sphingolipids has been established in a multitude of cellular events, including cell survival, growth, senescence and apoptosis, inflammation, and neovascularization. We discuss our current knowledge and understanding of sphingolipid metabolism and signaling in the pathogenesis of ocular diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FTY720; ceramide; retina; retinal degenerations; sphingolipid; sphingosine; uveitis

Mesh:

Substances:

Year:  2013        PMID: 24011710      PMCID: PMC3864975          DOI: 10.1016/j.survophthal.2013.02.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  149 in total

1.  Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E.

Authors:  Kamesh Ayasolla; Mushfiquddin Khan; Avtar K Singh; Inderjit Singh
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

2.  Diagnostic and predictive methods for a Niemann-Pick disease type B patient with ocular involvement.

Authors:  Cinoo Kim; Jinho Jeong; Hyeong Gon Yu
Journal:  J Inherit Metab Dis       Date:  2010-06-29       Impact factor: 4.982

Review 3.  Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation.

Authors:  Nadia F Lamour; Charles E Chalfant
Journal:  Mol Interv       Date:  2005-12

Review 4.  The ins and outs of sphingolipid synthesis.

Authors:  Anthony H Futerman; Howard Riezman
Journal:  Trends Cell Biol       Date:  2005-06       Impact factor: 20.808

Review 5.  Cell regulation by sphingosine and more complex sphingolipids.

Authors:  A H Merrill
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

6.  Targeted knockdown of Cerkl, a retinal dystrophy gene, causes mild affectation of the retinal ganglion cell layer.

Authors:  Alejandro Garanto; Javier Vicente-Tejedor; Marina Riera; Pedro de la Villa; Roser Gonzàlez-Duarte; Román Blanco; Gemma Marfany
Journal:  Biochim Biophys Acta       Date:  2012-04-19

7.  Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.

Authors:  Michel Baudry; Yuequin Yao; Danielle Simmons; Jihua Liu; Xiaoning Bi
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

Review 8.  GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.

Authors:  Nicola Brunetti-Pierri; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2008-06-03       Impact factor: 4.797

9.  In vivo CNS demyelination mediated by anti-galactocerebroside antibody.

Authors:  K Ozawa; T Saida; K Saida; H Nishitani; M Kameyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.

Authors:  S Anand Trip; Patricio G Schlottmann; Stephen J Jones; Daniel R Altmann; David F Garway-Heath; Alan J Thompson; Gordon T Plant; David H Miller
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

View more
  18 in total

1.  [Cherry-red spot in a 13-month-old child].

Authors:  B Hohberger; N Stenger; R Trollmann; C Y Mardin; G-C Gusek-Schneider
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

2.  Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress.

Authors:  Eriko Sugano; Genea Edwards; Saikat Saha; Lynda A Wilmott; Richard C Grambergs; Koushik Mondal; Hui Qi; Megan Stiles; Hiroshi Tomita; Nawajes Mandal
Journal:  J Lipid Res       Date:  2018-11-09       Impact factor: 5.922

3.  Analysis of sphingolipid composition in human vitreous from control and diabetic individuals.

Authors:  Lynda A Wilmott; Richard C Grambergs; Jeremy C Allegood; Timothy J Lyons; Nawajes Mandal
Journal:  J Diabetes Complications       Date:  2018-12-14       Impact factor: 2.852

4.  Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.

Authors:  Helena Jahnová; Helena Poupětová; Jitka Jirečková; Hana Vlášková; Eva Košťálová; Radim Mazanec; Alena Zumrová; Petr Mečíř; Zuzana Mušová; Martin Magner
Journal:  J Neurol       Date:  2019-05-10       Impact factor: 4.849

Review 5.  Emerging roles for sphingolipids in cellular aging.

Authors:  Pushpendra Singh; Rong Li
Journal:  Curr Genet       Date:  2017-12-19       Impact factor: 3.886

6.  An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD).

Authors:  Sara Tucci
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

7.  Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.

Authors:  Megan Stiles; Hui Qi; Eleanor Sun; Jeremy Tan; Hunter Porter; Jeremy Allegood; Charles E Chalfant; Douglas Yasumura; Michael T Matthes; Matthew M LaVail; Nawajes A Mandal
Journal:  J Lipid Res       Date:  2016-03-05       Impact factor: 5.922

Review 8.  Fingolimod: therapeutic mechanisms and ocular adverse effects.

Authors:  P Mandal; A Gupta; W Fusi-Rubiano; P A Keane; Y Yang
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

9.  Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition.

Authors:  Vikram Paranjpe; Jeremy Tan; Jason Nguyen; John Lee; Jeremy Allegood; Anat Galor; Nawajes Mandal
Journal:  Ocul Surf       Date:  2018-12-12       Impact factor: 6.268

Review 10.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.